CELL BIOTECH CO ., LTD Logo

CELL BIOTECH CO ., LTD

Develops and manufactures probiotic solutions using patented dual-coating technology.

049960 | KO

Overview

Corporate Details

ISIN(s):
KR7049960008
LEI:
Country:
South Korea
Address:
경기 김포시 월곶면 개곡리 134, 김포시

Description

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-17 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2023-02-17 00:00
현금ㆍ현물배당결정
Korean 8.4 KB
2022-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2022-12-01 00:00
주식등의대량보유상황보고서(약식)
Korean 386.1 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 756.4 KB
2022-11-08 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2022-08-18 00:00
신탁계약해지결과보고서
Korean 17.7 KB
2022-08-16 00:00
반기보고서 (2022.06)
Korean 897.5 KB
2022-08-08 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2022-06-10 00:00
주식등의대량보유상황보고서(약식)
Korean 326.1 KB
2022-05-19 00:00
신탁계약에의한취득상황보고서
Korean 31.3 KB
2022-05-16 00:00
분기보고서 (2022.03)
Korean 893.3 KB
2022-05-10 00:00
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2022-04-29 00:00
소속부변경
Korean 3.6 KB
2022-03-30 00:00
정기주주총회결과
Korean 30.4 KB

Automate Your Workflow. Get a real-time feed of all CELL BIOTECH CO ., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CELL BIOTECH CO ., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CELL BIOTECH CO ., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.